WO2006129092A3 - Use of bacteriophage in medicaments - Google Patents
Use of bacteriophage in medicaments Download PDFInfo
- Publication number
- WO2006129092A3 WO2006129092A3 PCT/GB2006/001992 GB2006001992W WO2006129092A3 WO 2006129092 A3 WO2006129092 A3 WO 2006129092A3 GB 2006001992 W GB2006001992 W GB 2006001992W WO 2006129092 A3 WO2006129092 A3 WO 2006129092A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- medicaments
- treatment
- bacteriophages
- prevention
- relates
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/00032—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Abstract
The present invention relates to medicaments suitable for use in the prevention and/or treatment of bacterial infection and/or colonisation. More particularly, the invention relates to medicaments comprising bacteriophages capable of binding to bacterial efflux pump components suitable for use in the prevention or treatment of diseases associated with Gram-negative bacteria. The invention also provides methods of treatment and methods of food preparation utilising such bacteriophages, as well as an assay by which such bacteriophages may be identified.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0511204.0A GB0511204D0 (en) | 2005-06-02 | 2005-06-02 | Medicaments |
GB0511204.0 | 2005-06-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2006129092A2 WO2006129092A2 (en) | 2006-12-07 |
WO2006129092A3 true WO2006129092A3 (en) | 2007-01-18 |
Family
ID=34834990
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB2006/001992 WO2006129092A2 (en) | 2005-06-02 | 2006-06-02 | Use of bacteriophage in medicaments |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB0511204D0 (en) |
WO (1) | WO2006129092A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070292397A1 (en) * | 2006-06-19 | 2007-12-20 | Mcnulty Amy K | Method for the detection and neutralization of bacteria |
EP2030623A1 (en) | 2007-08-17 | 2009-03-04 | Nestec S.A. | Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
WO2009104731A1 (en) * | 2008-02-21 | 2009-08-27 | 味の素株式会社 | L-cysteine-producing bacterium, and method for production of l-cysteine |
EP3448400A4 (en) * | 2016-04-25 | 2019-11-13 | Yale University | Bacteriophage compositions and uses thereof |
CN106868179A (en) * | 2017-03-30 | 2017-06-20 | 佟青 | Efflux pump SMeDEF combines the method for mediation germ oligotrophy unit cell Multiresistant genes positioning with I class integrase gene |
CN111088269B (en) * | 2019-12-17 | 2020-11-20 | 中国科学院深圳先进技术研究院 | OprJ-N-M fusion gene, fusion protein thereof, preparation method of fusion protein and application |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995023848A1 (en) * | 1994-03-01 | 1995-09-08 | Merck Patent Gmbh | Selective virus culture |
WO2002038104A2 (en) * | 2000-11-13 | 2002-05-16 | Iowa State University Research Foundation, Inc. | Compositions and methods for reducing the amount of salmonella in livestock |
WO2003103578A2 (en) * | 2002-06-05 | 2003-12-18 | Iowa State University Research Foundation, Inc. | Bacteriophage and enzymes lytic to salmonellae |
WO2005023010A2 (en) * | 2003-09-05 | 2005-03-17 | The University Of Nottingham | Disinfection of foodstuffs |
-
2005
- 2005-06-02 GB GBGB0511204.0A patent/GB0511204D0/en not_active Ceased
-
2006
- 2006-06-02 WO PCT/GB2006/001992 patent/WO2006129092A2/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995023848A1 (en) * | 1994-03-01 | 1995-09-08 | Merck Patent Gmbh | Selective virus culture |
WO2002038104A2 (en) * | 2000-11-13 | 2002-05-16 | Iowa State University Research Foundation, Inc. | Compositions and methods for reducing the amount of salmonella in livestock |
WO2003103578A2 (en) * | 2002-06-05 | 2003-12-18 | Iowa State University Research Foundation, Inc. | Bacteriophage and enzymes lytic to salmonellae |
WO2005023010A2 (en) * | 2003-09-05 | 2005-03-17 | The University Of Nottingham | Disinfection of foodstuffs |
Non-Patent Citations (8)
Title |
---|
ANDERSON E S ET AL: "Bacteriophage typing of enteric pathogens and staphylococci and its use in epidemiology.", JOURNAL OF CLINICAL PATHOLOGY. MAY 1956, vol. 9, no. 2, May 1956 (1956-05-01), pages 94 - 127, XP002404413, ISSN: 0021-9746 * |
CARLTON R M: "PHAGE THERAPY: PAST HISTORY AND FUTURE PROSPECTS", ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, POLISH ACADEMY OF SCIENCES, WROCLAW, PL, vol. 47, no. 5, 1999, pages 267 - 274, XP001199870, ISSN: 0004-069X * |
CONNERTON P L ET AL: "Longitudinal study of Campylobacter jejuni bacteriophages and their hosts from broiler chickens", APPLIED AND ENVIRONMENTAL MICROBIOLOGY, WASHINGTON,DC, US, vol. 70, no. 7, July 2004 (2004-07-01), pages 3877 - 3883, XP002313914, ISSN: 0099-2240 * |
EL-SHIBINY A ET AL: "Enumeration and diversity of campylobacters and bacteriophages isolated during the rearing cycles of free-range and organic chickens.", APPLIED AND ENVIRONMENTAL MICROBIOLOGY. MAR 2005, vol. 71, no. 3, March 2005 (2005-03-01), pages 1259 - 1266, XP002404410, ISSN: 0099-2240 * |
GERMAN G J ET AL: "The TolC protein of Escherichia coli serves as a cell-surface receptor for the newly characterized TLS bacteriophage", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB, vol. 308, no. 4, 11 May 2001 (2001-05-11), pages 579 - 585, XP004480454, ISSN: 0022-2836 * |
HUSAIN FASAHATH ET AL: "Interaction between the TolC and AcrA proteins of a multidrug efflux system of Escherichia coli.", JOURNAL OF BACTERIOLOGY. DEC 2004, vol. 186, no. 24, December 2004 (2004-12-01), pages 8533 - 8536, XP002404027, ISSN: 0021-9193 * |
SCHMIEGER H: "Molecular survey of the Salmonella phage typing system of Anderson.", JOURNAL OF BACTERIOLOGY. MAR 1999, vol. 181, no. 5, March 1999 (1999-03-01), pages 1630 - 1635, XP002404411, ISSN: 0021-9193 * |
THIEL KARL: "Old dogma, new tricks--21st Century phage therapy.", NATURE BIOTECHNOLOGY. JAN 2004, vol. 22, no. 1, January 2004 (2004-01-01), pages 31 - 36, XP002404412, ISSN: 1087-0156 * |
Also Published As
Publication number | Publication date |
---|---|
GB0511204D0 (en) | 2005-07-06 |
WO2006129092A2 (en) | 2006-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006013441A3 (en) | Use of probiotic bacteria for the preparation of topical compositions for skin protection | |
WO2012003474A3 (en) | Compositions and methods related to protein a (spa) variants | |
WO2011110655A3 (en) | Immunogenic composition or vaccine against gram - negative bacterial, for example neiserial, infection or disease | |
IL213489A0 (en) | Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces | |
WO2005089738A3 (en) | Use and administration of bacterial efflux pump inhibitors | |
WO2005103084A3 (en) | Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof | |
WO2007085852A3 (en) | Antimicrobial materials | |
WO2010090860A3 (en) | Methods and compositions for treating bacterial infection | |
WO2007090569A8 (en) | Conditioned blood composition and method for its production | |
EP2730576A3 (en) | Anti-infective compounds | |
WO2005072826A3 (en) | Compositions and use of tyrosine kinase inhibitors to treat pathogenic infection | |
WO2006020773A3 (en) | Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use | |
WO2007141274A3 (en) | Human binding molecules having killing activity against staphylococci and uses thereof | |
AU2011206532A8 (en) | Recombinant probiotic bacteria for the prevention and treatment of inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) | |
WO2009129246A3 (en) | Compositions and methods for preparing and using same | |
WO2008036932A3 (en) | Compositions and methods comprising boswellia species | |
EP2772260A3 (en) | Therapeutic compositions comprising hyaluronan and therapeutic antibodies as well as methods of treatment | |
WO2009108406A3 (en) | Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof | |
WO2009088549A3 (en) | Methods of inhibiting bacterial virulence and compounds relating thereto | |
WO2006129092A3 (en) | Use of bacteriophage in medicaments | |
WO2007117680A3 (en) | Methods and compositions for treating bacterial infection | |
WO2007126363A8 (en) | Antisecretory protein for use in the treatment of compartment syndrome | |
WO2007071658A3 (en) | Alkyl phospholipid derivatives with reduced cytotoxicity and uses thereof | |
WO2008017826A3 (en) | Immunogenic proteins of burkholderia pseudomallei and uses thereof | |
WO2011047320A3 (en) | Antimicrobial compounds and methods of making and using the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 06744053 Country of ref document: EP Kind code of ref document: A2 |